Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S4 from TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer
  1. Home
  2. Publications
  3. Supplementary Table S4 from TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer

Supplementary Table S4 from TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer

Authors:
  • RARosa A. van Amerongen
    Rosa A. van Amerongen
  • STSander Tuit
    Sander Tuit
  • DRDennis F.G. Remst
    Dennis F.G. Remst
  • AWAnne K. Wouters
    Anne K. Wouters
  • SSSterre L. Siekman
    Sterre L. Siekman
  • RHRenate S. Hagedoorn
    Renate S. Hagedoorn
  • DSDirk M. van der Steen
    Dirk M. van der Steen
  • MKMichel G.D. Kester
    Michel G.D. Kester
  • ARArnoud H. de Ru
    Arnoud H. de Ru
  • GHGeertje van der Horst
    Geertje van der Horst
  • MMMasashi Matsuda
    Masashi Matsuda
  • FIFumihiko Ishikawa
    Fumihiko Ishikawa

Open Access
Publisher website
Google Scholar
  • 1 August 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.29759645
Abstract
No abstract available
Keywords
  • GENITOURINARY CANCERS
  • PROSTATE CANCER
  • IMMUNOLOGY
  • TUMOR ANTIGENS/NEOANTIGENS
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
  • PRECLINICAL MODELS
  • ANIMAL MODELS OF CANCER
  • IN VITRO MODELS OF CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.